Celldex Therapeutics, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2020-06-11

Reporting Person: Young Diane C. (SVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-11	Common stock, par value $0.001 per share	P	2115	$4.73	Acquired	2115	Direct